Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00258271
Status:
COMPLETED
Last Update Posted:
2013-10-16
First Post:
2005-11-22
Brief Title:
Cladribine Cytarabine and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia
Sponsor:
Organization:
University of Rochester